English | Español

Bristol-Myers Squibb
Robert Hadley | May 14, 2017

Bristol-Myers Squibb dual-drug treatment for hepatitis C gains China approval
Robert Hadley | May 14, 2017

Partnership to launch study of two drugs, chemotherapy to treat lung cancer
Chandra Lye | May 11, 2017

Opdivo given European approval for patients with head and neck squamous cell cancer
Robert Hadley | Apr 14, 2017

FDA to speed Opdivo review for use as colorectal cancer drug
Robert Hadley | Apr 10, 2017

Bristol-Myers Squibb to contunue testing Opdivo for brain tumors
Robert Hadley | Apr 7, 2017

Early tests show Opdivo triples life expectancy in lung-cancer patients
Kyle Perrotti | Apr 6, 2017

Parker Institute, Cancer Research Institute join forces for project
Erianne Leatherman | Apr 5, 2017

BMS, Foundation Medicine partner on predictive biomarker project

Trending
Patient Daily | Oct 9, 2025

Medfluence Advisors Marketing Expert: 'The conversations leading into AAO-HNSF are shaping how ENT practices approach growth and engagement'
+ Technology/Innovation
Patient Daily News Service | Oct 9, 2025

Babylon Health collapse raises questions about AI claims across industries
Patient Daily | Oct 9, 2025

AI takes center stage at ASCENT ENT conference, reshaping marketing and operations
+ Regulatory
Patient Daily | Oct 14, 2025

Mackinac Center raises concerns over federal 340B drug pricing program’s market impact